SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 47 850 KRW -1.34% Market Closed
Market Cap: 3.7T KRW
Have any thoughts about
SK Bioscience Co Ltd?
Write Note

SK Bioscience Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SK Bioscience Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
SK Bioscience Co Ltd
KRX:302440
Other Current Liabilities
â‚©104.4B
CAGR 3-Years
-9%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Other Current Liabilities
â‚©430.7B
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
18%
Green Cross Corp
KRX:006280
Other Current Liabilities
â‚©131.4B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
8%
H
Hugel Inc
KOSDAQ:145020
Other Current Liabilities
â‚©42.2B
CAGR 3-Years
16%
CAGR 5-Years
22%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Other Current Liabilities
â‚©40.1B
CAGR 3-Years
41%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Current Liabilities
â‚©12.8B
CAGR 3-Years
21%
CAGR 5-Years
39%
CAGR 10-Years
N/A
No Stocks Found

SK Bioscience Co Ltd
Glance View

Market Cap
3.7T KRW
Industry
Biotechnology

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-03-18. The firm's main products include vaccines such as SKYCellflu and Rotatech. The firm also sells infusion solutions. In addition, the Company engages in technology export business. The firm sells its products in domestic and overseas markets.

Intrinsic Value
35 489.69 KRW
Overvaluation 26%
Intrinsic Value
Price

See Also

What is SK Bioscience Co Ltd's Other Current Liabilities?
Other Current Liabilities
104.4B KRW

Based on the financial report for Dec 31, 2023, SK Bioscience Co Ltd's Other Current Liabilities amounts to 104.4B KRW.

What is SK Bioscience Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
35%

Over the last year, the Other Current Liabilities growth was -57%. The average annual Other Current Liabilities growth rates for SK Bioscience Co Ltd have been -9% over the past three years , 35% over the past five years .

Back to Top